OEC turns in healthy 1998 results

Article

Mobile C-arm manufacturer OEC Medical Systems of Salt Lake City posted robust numbers for fiscal 1998 (end-December). The company's fourth-quarter revenues climbed 19%, from $45.3 million in 1997 to $53.7 million. The company's net income for the fourth

Mobile C-arm manufacturer OEC Medical Systems of Salt Lake City posted robust numbers for fiscal 1998 (end-December). The company's fourth-quarter revenues climbed 19%, from $45.3 million in 1997 to $53.7 million. The company's net income for the fourth quarter was $4.7 million, increasing over 1997's $3.7 million.

Revenue for the year increased 21%, reaching $188.7 million, compared with $155.4 million the year before. OEC's net income for the year was $16.1 million versus $12.2 million last year, a 32% increase. OEC said it recorded healthy gains in both product sales and service revenue.

In other OEC news, the company on Jan. 15 chose Picker International Canada as its Canadian distributor. The appointment followed the respective purchases by Picker and General Electric Medical Systems' of Elscint Canada's CT and nuclear medicine businesses (SCAN 12/16/98 and 9/16/98). Elscint Canada was OEC's former Canadian distributor.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.